Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation
Abstract: The intensity of the conditioning regimen given before allogeneic hematopoietic cell transplantation (allo-HCT) can vary substantially. To confirm the ability of the recently developed transplant conditioning intensity (TCI) score to stratify the preparative regimens of allo-HCT, we used an independent and contemporary patient cohort of 4060 transplant recipients with acute myeloid leukemia meeting inclusion criteria from the discovery study (allo-HCT in first complete remission, matched donor), but who were allografted in a more recent period (2018–2021) and were one decade older (55–75 years, median 63.4 years), we assigned them to a TCI category (low n = 1934, 48%; intermediate n = 1948, 48%, high n = 178, 4%) according to the calculated TCI score ([1–2], [2.5–3.5], [4–6], respectively), and examined the validity of the TCI category in predicting early non-relapse mortality (NRM), 2-year NRM and relapse (REL). In the unadjusted comparison, the TCI index provided a significant risk stratification for d100 and d180 NRM, NRM and REL risk. In the multivariate analysis adjusted for significant variables, there was an independent association of TCI with early NRM, NRM and REL. In summary, we confirm in contemporary treated patients that TCI reflects the conditioning regimen related morbidity and anti-leukemic efficacy satisfactorily and across other established prognostic factors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Bone marrow transplantation. - 59, 2 (2024) , 217-223, ISSN: 1476-5365
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2023
- DOI
-
10.1038/s41409-023-02139-5
- URN
-
urn:nbn:de:bsz:25-freidok-2425866
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:43 MEZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Spyridonidis, Alexandros
- Finke, Jürgen
- Mohty, Mohamad
- Universität
Entstanden
- 2023
Ähnliche Objekte (12)
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients - evaluation of pre-transplant risk assessments
Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party
Strategies to prevent graft-versus-host disease and augment anti-fungal immunity in allogeneic hematopoietic stem cell transplant recipients
Excretion of Ascaris lumbricoides following reduced‐intensity allogeneic hematopoietic stem cell transplantation and consecutive treatment with mebendazole
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies
Reduced-intensity conditioning combined with 188rhenium radioimmunotherapy before allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia : the role of in vivo T cell depletion
Allogeneic hematopoietic stem cell transplantation for congenital immune dysregulatory disorders
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Pre-emptive allogeneic hematopoietic stem cell transplantation in ataxia telangiectasia
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients - evaluation of pre-transplant risk assessments
Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party
Strategies to prevent graft-versus-host disease and augment anti-fungal immunity in allogeneic hematopoietic stem cell transplant recipients
Excretion of Ascaris lumbricoides following reduced‐intensity allogeneic hematopoietic stem cell transplantation and consecutive treatment with mebendazole
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies
Reduced-intensity conditioning combined with 188rhenium radioimmunotherapy before allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia : the role of in vivo T cell depletion
Allogeneic hematopoietic stem cell transplantation for congenital immune dysregulatory disorders
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Pre-emptive allogeneic hematopoietic stem cell transplantation in ataxia telangiectasia
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients - evaluation of pre-transplant risk assessments
Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party
Strategies to prevent graft-versus-host disease and augment anti-fungal immunity in allogeneic hematopoietic stem cell transplant recipients
Excretion of Ascaris lumbricoides following reduced‐intensity allogeneic hematopoietic stem cell transplantation and consecutive treatment with mebendazole
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies
Reduced-intensity conditioning combined with 188rhenium radioimmunotherapy before allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia : the role of in vivo T cell depletion
Allogeneic hematopoietic stem cell transplantation for congenital immune dysregulatory disorders
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Pre-emptive allogeneic hematopoietic stem cell transplantation in ataxia telangiectasia